Deletion of the ST2 proximal promoter disrupts fibroblast-specific expression but does not reduce the amount of soluble ST2 in circulation

European Journal of Immunology

Volumn 42, Issue 7, 2012, Pages 1863-1869

  Lipsky, Brian P ^a   Toy, Dean Y ^a   Swart, David A ^a   Smithgall, Molly D ^a   Smith, Dirke ^a  

^a AMGEN INC   (United States)

Author keywords

IL 33; Knockout; Promoter; ST2

Indexed keywords

INTERLEUKIN 33; MESSENGER RNA; RECEPTOR; ST2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; FIBROBLAST; GENE DELETION; GENE EXPRESSION REGULATION; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; SPLEEN CELL;

ANIMALS; FIBROBLASTS; GENE EXPRESSION REGULATION; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPLEEN;

EID: 84864018937     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142274     Document Type: Article

References (21)

1. Hayakawa, H., Hayakawa, M., Kume, A. and Tominaga, S., Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 2007. 282: 26369-26380.
2. Tominaga, S., A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 1989. 258: 301-304.
3. Klemenz, R., Hoffmann, S. and Werenskiold, A. K., Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc. Natl. Acad. Sci. USA 1989. 86: 5708-5712.
4. Trub, T., Kalousek, M. B., Frohli, E. and Klemenz, R., Growth factor-mediated induction of the delayed early gene T1 depends on a 12-O-tetradecanoylphorbol 13-acetate-responsive element located 3.6 kb upstream of the transcription initiation site. Proc. Natl. Acad. Sci. USA 1994. 91: 3896-3900.
5. Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T. and Tominaga, S., Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 1993. 318: 83-87.
6. Gachter, T., Werenskiold, A. K. and Klemenz, R., Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J. Biol. Chem. 1996. 271: 124-129.
7. Hayakawa, M., Yanagisawa, K., Aoki, S., Hayakawa, H., Takezako, N. and Tominaga, S., T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3. Biochim. Biophys. Acta 2005. 1728: 53-64.
8. Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P. and Busslinger, M., Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO. J. 1994. 13: 1176-1188.
9. Oshikawa, K., Kuroiwa, K., Tago, K., Iwahana, H., Yanagisawa, K., Ohno, S., Tominaga, S. I. et al., Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 2001. 164: 277-281.
10. Becerra, A., Warke, R. V., de Bosch, N., Rothman, A. L. and Bosch, I., Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine 2008. 41: 114-120.
11. Kuroiwa, K., Arai, T., Okazaki, H., Minota, S. and Tominaga, S., Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem. Biophys. Res. Commun. 2001. 284: 1104-1108.
12. Shah, R. V. and Januzzi, J. L., Jr., ST2: a novel remodeling biomarker in acute and chronic heart failure. Curr. Heart Fail Rep. 2010. 7: 9-14.
13. Kumar, S., Tzimas, M. N., Griswold, D. E. and Young, P. R., Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem. Biophys. Res. Commun. 1997. 235: 474-478.
14. Lecart, S., Lecointe, N., Subramaniam, A., Alkan, S., Ni, D., Chen, R., Boulay, V., et al., Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. Eur. J. Immunol. 2002. 32: 2979-2987.
15. Prechtel, D., Harbeck, N., Berger, U., Hofler, H. and Werenskiold, A. K., Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Lab. Invest. 2001. 81: 159-165.
16. Haga, Y., Yanagisawa, K., Ohto-Ozaki, H., Tominaga, S., Masuzawa, T. and Iwahana, H., The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G. Eur. J. Biochem. 2003. 270: 163-170.
17. Kurokawa, M., Matsukura, S., Kawaguchi, M., Ieki, K., Suzuki, S., Odaka, M., Watanabe, S., et al., Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. Int. Arch. Allergy Immunol. 2011. 155(Suppl 1): 12-20.
18. Hueber, A. J., Alves-Filho, J. C., Asquith, D. L., Michels, C., Millar, N. L., Reilly, J. H., Graham, G. J. et al., IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur. J. Immunol. 2011. 41: 2229-2237.
19. Iwahana, H., Yanagisawa, K., Ito-Kosaka, A., Kuroiwa, K., Tago, K., Komatsu, N., Katashima, R., et al., Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur. J. Biochem. 1999. 264: 397-406.
20. Li, H., Tago, K., Io, K., Kuroiwa, K., Arai, T., Iwahana, H., Tominaga, S., et al., The cloning and nucleotide sequence of human ST2L cDNA. Genomics 2000. 67: 284-290.
21. Marvie, P., Lisbonne, M., L'Helgoualc'h, A., Rauch, M., Turlin, B., Preisser, L., Bourd-Boittin, et al., Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J. Cell Mol. Med. 2009. 14: 1726-1739.